NASDAQ:LYEL

Lyell Immunopharma Stock Forecast

etoro logo Buy LYEL
*Your capital is at risk
$17.42
+0.490 (+2.89%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of LYEL
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Big movements in Lyell Immunopharma, Inc. stock price on Monday moving 10.06% between high and low
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Nov 17, 2025

The Lyell Immunopharma, Inc. stock price gained 2.89% on the last trading day (Monday, 17th Nov 2025), rising from $16.93 to $17.42. During the last trading day the stock fluctuated 10.06% from a day low at $16.99 to a day high of $18.70. The price has been going up and down for this period, and there has been a 5.26% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 16 thousand more shares were traded than the day before. In total, 34 thousand shares were bought and sold for approximately $595.69 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $17.06 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 56.41% during the next 3 months and, with a 90% probability hold a price between $26.68 and $34.81 at the end of this 3-month period.

LYEL Signals & Forecast

The Lyell Immunopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $17.40 and $17.17. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Lyell Immunopharma, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, October 09, 2025, and so far it has fallen -7.68%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Lyell Immunopharma, Inc. stock

Lyell Immunopharma, Inc. finds support from accumulated volume at $16.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.71 between high and low, or 10.06%. For the last week, the stock has had daily average volatility of 8.10%.

Our recommended stop-loss: $16.56 (-4.96%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 27 days ago.)

Trading Expectations (LYEL) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Lyell Immunopharma, Inc. to open at $17.70, and during the day (based on 14 day Average True Range), to move between $16.78 and $18.06, which gives a possible trading interval of +/-$1.28 (+/-7.63%) up or down from last closing price. If Lyell Immunopharma, Inc. takes out the full calculated possible swing range there will be an estimated 7.63% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $17.75 (1.89%) than the support at $16.55 (4.99%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Lyell Immunopharma, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Lyell Immunopharma, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 3.246 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $17.70 ( 1.63%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

LYEL Performance

Trading levels for LYEL

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 19.41 11.44%
R2 18.76 7.69%
R1 18.36 5.38%
Price 17.42
S1 17.05 -2.12%
S2 16.65 -4.44%
S3 15.99 -8.19%

Accumulated Volume Support & Resistance Levels

Level Price
R3 18.87 8.32%
R2 18.32 5.17%
R1 17.75 1.89%
Price 17.42
S1 16.55 -4.99%
S2 13.17 -24.40%
S3 13.09 -24.86%

FAQ

What is the symbol for Lyell Immunopharma, Inc. Stock and on which exchange is it traded?
The symbol for Lyell Immunopharma, Inc. is LYEL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lyell Immunopharma, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Lyell Immunopharma, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Lyell Immunopharma, Inc. Stock?
Lyell Immunopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lyell Immunopharma, Inc. Stock.

What's the current price of Lyell Immunopharma, Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Lyell Immunopharma, Inc. (LYEL) share was $17.42.

What is the 52-week high and low for Lyell Immunopharma, Inc. Stock?
The 52-week high for Lyell Immunopharma, Inc. Stock is $23.20 and the 52-week low is $7.65.

What is the market capitalization of Lyell Immunopharma, Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Lyell Immunopharma, Inc. is 369.613M.
Click to get the best stock tips daily for free!
ABOUT LYELL IMMUNOPHARMA, INC.
Lyell Immunopharma
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate ...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE